How a clever new strategy of molecular jamming is taking aim at a notoriously undruggable pathway in cancer through novel peptides targeting the β-catenin/TBL1 complex.
Discover how tyrosine phosphorylation of β-catenin drives drug resistance in EGFR-mutant lung cancer and the promising research behind this molecular mechanism.
Discover how AKR1C3 and AR-V7 work together to create treatment resistance in advanced prostate cancer and the emerging therapeutic strategies to overcome this challenge.
Discover how MUC1 deficiency triggers nasal epithelial barrier dysfunction through RBFOX3 shortage and ubiquitin-proteasomal degradation in allergic rhinitis pathogenesis.
Discover how SUMOylation controls Polo-like Kinase 1 (Plk1) nuclear import and stability, revealing new insights into cell division and cancer therapy.
Exploring the diagnostic revolution for Frontotemporal Lobar Degeneration and Dementia with Lewy Bodies through advanced biomarkers and imaging technologies.
Explore how AI, telemedicine, robotics, and wearable technology are transforming healthcare delivery and improving patient outcomes.
Explore the fascinating world of the ubiquitin-proteasome system - the cellular machinery that controls protein degradation and its crucial role in neurodegeneration, aging, and cancer.
Discover how BARD1 gene research is transforming breast cancer screening, prevention, and treatment for predisposed women.
Explore how gene product-targeting therapy is revolutionizing leukemia treatment through precision medicine approaches.